(Q42804376)

7 November 2017

title

Characterization of an imatinib-sensitive subset of high-grade human glioma cultures (English)

1 reference

7 November 2017

0 references

1

1 reference

7 November 2017

8

1 reference

7 November 2017

Hesselager G

2

1 reference

7 November 2017

Achterberg S

3

1 reference

7 November 2017

Wickenberg Bolin U

4

1 reference

7 November 2017

Kowanetz M

5

1 reference

7 November 2017

Kastemar M

6

1 reference

7 November 2017

Heldin CH

7

1 reference

7 November 2017

Nister M

9

1 reference

7 November 2017

Ostman A

10

1 reference

7 November 2017

language of work or name

English

0 references

publication date

20 March 2006

1 reference

7 November 2017

1 reference

7 November 2017

volume

25

1 reference

7 November 2017

issue

35

1 reference

7 November 2017

page(s)

4913-4922

1 reference

describes a project that uses

7 November 2017

U-2987MG

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209497

0 references

cites work

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Gene expression profiling of gliomas strongly predicts survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Epidermal growth factor receptor mutations in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

The WHO classification of tumors of the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Identification of molecular subtypes of glioblastoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Genetic pathways to glioblastoma: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

PDGF receptors as cancer drug targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Phase II trial of gefitinib in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Platelet-derived growth factor in human glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Isolation of cancer stem cells from adult glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209497

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209497

1 reference

Dimensions Publication ID

7 November 2017

1037671268

0 references

1 reference